Background

Beginning in the 1990s, non-medical use of prescription opioids (POs) became a major public health crisis. In response to rising rates of opioid dependence and fatal poisonings, measures were instituted to decrease the prescription, diversion, and non-medical use of POs including prescription drug monitoring programs (PDMPs), pain clinic laws, prescription duration limits, disciplining doctors who prescribed an excessive number of POs, and the advent of abuse deterrent formulations of POs. This paper explores the unintended effects of these policies in the descriptions of why...

Background

Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioids. Medications for opioid use disorder (MOUD; e.g., buprenorphine) are effective, evidence-based treatments that can be delivered in office-based primary care settings. We investigated disparities in the proportion of national prescribers who have obtained a waiver issued to prescribe MOUD by demographic characteristics.

Methods

Data for the secondary data analyses were...

Background

When used in combination with other therapies for drug use disorders, neurofeedback (NF) has been classified as "probably effective," according to recent research in the community of people with opioid use disorder. Despite these encouraging results, the severity of the opioid crisis, and the high risk of relapse even with the most effective medication-assisted maintenance therapy, NF remains a little-studied therapeutic option. The possibility of incorporating Alpha/Theta Neurofeedback into standard opioid addiction therapy in an outpatient urban treatment facility is examined in...